company background image
600521 logo

Zhejiang Huahai Pharmaceutical SHSE:600521 Stock Report

Last Price

CN¥17.57

Market Cap

CN¥25.3b

7D

-1.2%

1Y

-3.2%

Updated

17 Jul, 2024

Data

Company Financials +

Zhejiang Huahai Pharmaceutical Co., Ltd.

SHSE:600521 Stock Report

Market Cap: CN¥25.3b

600521 Stock Overview

Operates as a pharmaceutical company in China and internationally.

600521 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth3/6
Past Performance2/6
Financial Health4/6
Dividends4/6

Zhejiang Huahai Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Zhejiang Huahai Pharmaceutical
Historical stock prices
Current Share PriceCN¥17.57
52 Week HighCN¥19.09
52 Week LowCN¥10.71
Beta0.097
11 Month Change1.09%
3 Month Change16.82%
1 Year Change-3.20%
33 Year Change-23.77%
5 Year Change20.49%
Change since IPO648.37%

Recent News & Updates

Recent updates

Zhejiang Huahai Pharmaceutical Co., Ltd.'s (SHSE:600521) Intrinsic Value Is Potentially 89% Above Its Share Price

Jun 20
Zhejiang Huahai Pharmaceutical Co., Ltd.'s (SHSE:600521) Intrinsic Value Is Potentially 89% Above Its Share Price

Zhejiang Huahai Pharmaceutical (SHSE:600521) Takes On Some Risk With Its Use Of Debt

May 28
Zhejiang Huahai Pharmaceutical (SHSE:600521) Takes On Some Risk With Its Use Of Debt

There May Be Some Bright Spots In Zhejiang Huahai Pharmaceutical's (SHSE:600521) Earnings

May 06
There May Be Some Bright Spots In Zhejiang Huahai Pharmaceutical's (SHSE:600521) Earnings

Investors Don't See Light At End Of Zhejiang Huahai Pharmaceutical Co., Ltd.'s (SHSE:600521) Tunnel

Mar 22
Investors Don't See Light At End Of Zhejiang Huahai Pharmaceutical Co., Ltd.'s (SHSE:600521) Tunnel

Shareholder Returns

600521CN PharmaceuticalsCN Market
7D-1.2%1.0%1.0%
1Y-3.2%-15.8%-18.1%

Return vs Industry: 600521 exceeded the CN Pharmaceuticals industry which returned -15.8% over the past year.

Return vs Market: 600521 exceeded the CN Market which returned -18.1% over the past year.

Price Volatility

Is 600521's price volatile compared to industry and market?
600521 volatility
600521 Average Weekly Movement4.8%
Pharmaceuticals Industry Average Movement5.4%
Market Average Movement6.2%
10% most volatile stocks in CN Market9.4%
10% least volatile stocks in CN Market4.1%

Stable Share Price: 600521's share price has been volatile over the past 3 months.

Volatility Over Time: 600521's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19898,221Bao Hua Chenwww.huahaipharm.com

Zhejiang Huahai Pharmaceutical Co., Ltd. operates as a pharmaceutical company in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also provides packaging components, such as high-density polyethylene bottles and polypropylene caps for pharmaceuticals.

Zhejiang Huahai Pharmaceutical Co., Ltd. Fundamentals Summary

How do Zhejiang Huahai Pharmaceutical's earnings and revenue compare to its market cap?
600521 fundamental statistics
Market capCN¥25.30b
Earnings (TTM)CN¥928.37m
Revenue (TTM)CN¥8.75b

27.4x

P/E Ratio

2.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
600521 income statement (TTM)
RevenueCN¥8.75b
Cost of RevenueCN¥3.54b
Gross ProfitCN¥5.21b
Other ExpensesCN¥4.28b
EarningsCN¥928.37m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 31, 2024

Earnings per share (EPS)0.64
Gross Margin59.59%
Net Profit Margin10.61%
Debt/Equity Ratio96.2%

How did 600521 perform over the long term?

See historical performance and comparison

Dividends

1.1%

Current Dividend Yield

31%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.